MSCRF Discovery Program
Forecasted
The MSCRF Discovery Program from TEDCO funds innovative human stem cell research in Maryland, supporting novel basic and translational science to advance regenerative medicine.
Funder: Maryland Technology Development Corporation (TEDCO)
Due Dates (Anticipated): January 2027 (Application submission deadline, projected)
Funding Amounts: Up to $350,000 per award, maximum 2 years; indirect costs capped at 15% of direct costs.
Summary: Supports innovative human stem cell research in Maryland, advancing basic and translational science in regenerative medicine.
Key Information: All research must be conducted in Maryland and involve human stem cells; see eligibility and application requirements.
Description
The Discovery Program of the Maryland Stem Cell Research Fund (MSCRF), administered by TEDCO, aims to accelerate novel and high-impact stem cell research in Maryland. The program funds both basic and translational projects that utilize human stem cells, their derivatives, or enabling technologies to address significant medical challenges. Priority is given to projects proposing new hypotheses, approaches, or models that push the boundaries of current stem cell science. Awardees are expected to share research results and materials, adhere to rigorous ethical standards, and contribute to the broader scientific community through open data and publication.
